Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vericel (VCEL) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Vericel (VCEL) over the last 15 years, with Sep 2025 value amounting to $17.9 million.

  • Vericel's Cost of Revenue rose 10.25% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.7 million, marking a year-over-year increase of 4.66%. This contributed to the annual value of $65.1 million for FY2024, which is 5.13% up from last year.
  • Vericel's Cost of Revenue amounted to $17.9 million in Q3 2025, which was up 7.76% from $16.6 million recorded in Q2 2025.
  • Vericel's Cost of Revenue's 5-year high stood at $17.9 million during Q3 2025, with a 5-year trough of $11.6 million in Q1 2021.
  • For the 3-year period, Vericel's Cost of Revenue averaged around $16.2 million, with its median value being $16.3 million (2024).
  • Data for Vericel's Cost of Revenue shows a peak YoY surged of 45.60% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Vericel's Cost of Revenue stood at $13.6 million in 2021, then grew by 6.53% to $14.4 million in 2022, then climbed by 14.15% to $16.5 million in 2023, then increased by 2.35% to $16.9 million in 2024, then climbed by 10.25% to $17.9 million in 2025.
  • Its Cost of Revenue was $17.9 million in Q3 2025, compared to $16.6 million in Q2 2025 and $16.3 million in Q1 2025.